highly significantP = 1.25e−05
Replacing the RTK-RAS amplification with the RTK-RAS-MYC amplification in the Cox regression model controlling clinical features led to an increase of the R -square from 0.165 to 0.173, and both NFE2L2 mutation and RTK-RAS-MYC amplification were highly significant ( P = 1.25e−05 and 5.11e−4, respectively, Supplementary information, Table S16b ).